Periprocedural Outcomes of VT Ablation in Ischemic Compared to Non‐Ischemic Dilated Cardiomyopathy
Annals of Noninvasive Electrocardiology · 2025
DOI: 10.1111/anec.70126 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Annals of Noninvasive Electrocardiology, 2025. Verfasst von Sanchit Duhan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Carle Foundation Hospital, University of Illinois Urbana-Champaign, Champaign, Illinois, USA. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Catheter Ablation, Myocardial Ischemia, Tachycardia, Ventricular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Patients with structural heart disease undergoing catheter ablation (CA) for VT have shown higher procedural‐related adverse events. However, periprocedural outcomes comparing CA for VT in different cardiomyopathies are not well known. We aim to study short‐term outcomes of CA in ischemic (ICM) compared to non‐ischemic dilated cardiomyopathy (NIDCM).
Methods
The national readmission database (2016–2020) was used to identify hospitalizations for CA for VT. Cohorts were stratified based on underlying cardiomyopathy. A Propensity Score Matching (PSM) model matched ICM to NIDCM patients. Pearson's Chi‐squared test was applied to PSM‐matched cohorts to compare outcomes.
Results
Among 7081 hospitalizations for VT ablation, 17.5% of patients had underlying NIDCM, while 82.5% of patients had ICM. On a PSM analysis ( N : 3534), ICM patients had higher incidences of sudden cardiac arrest (SCA) (7.9% vs. 5.6%, p < 0.001), major adverse cardiac events (11.1% vs. 9%, p : 0.006), and cardiogenic shock (10.8% vs. 8.5%, p : 0.001). Interestingly, NIDCM patients were found to have much higher rates of pericardial complications (6.09% vs. 1.90%, p < 0.001), while the mortality difference was not significant ( p > 0.05). From 2016 to 2020, in‐hospital mortality rates have not changed significantly in ICM and NIDCM cases admitted for VT ablation ( p ‐trend > 0.05); however, there was a decreasing trend of SCA cases in NIDCM hospitalizations (8.7%–3.4%, p ‐trend: 0.028). NIDCM patients had higher readmission rates at 30 days (18% vs. 15.5%, p : 0.01), 90‐day (32.3% vs. 29.6%, p : 0.041), and 180‐day (44% vs. 38.2%, p : 0.001).
Conclusion
VT ablation in ICM patients was associated with higher non‐fatal periprocedural events. NIDCM patients showed higher all‐cause readmission rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Carle Foundation Hospital, University of Illinois Urbana-Champaign, Champaign, Illinois, USA.
- Department of Internal Medicine, Louisiana State University, Shreveport, Louisiana, USA.
- Department of Internal Medicine, Cook County Hospital, Chicago, Illinois, USA.
- Department of Internal Medicine, Shandong Second Medical University, Weifang, Shandong, China.
ORCID-Profile: Sanchit Duhan
Zitieren
APA
Duhan, S., Ali, S., Alsaeed, T., Kumar, M., Keisham, B., S Mehta, S., Adoni, N. A., Mongwa, M., Rhee, B. J., & Garg, A. (2025). Periprocedural Outcomes of VT Ablation in Ischemic Compared to Non‐Ischemic Dilated Cardiomyopathy. Annals of Noninvasive Electrocardiology. https://doi.org/10.1111/anec.70126
Vancouver
Duhan S, Ali S, Alsaeed T, Kumar M, Keisham B, S Mehta S, et al. Periprocedural Outcomes of VT Ablation in Ischemic Compared to Non‐Ischemic Dilated Cardiomyopathy. Annals of Noninvasive Electrocardiology. 2025. doi:10.1111/anec.70126
BibTeX
@article{Duhan2025,
author = {Duhan, Sanchit and Ali, Shafaqat and Alsaeed, Thannon and Kumar, Manoj and Keisham, Bijeta and S Mehta, Sanjay and Adoni, Naveed A and Mongwa, Mbu and Rhee, Benjamin J and Garg, Anuj},
title = {Periprocedural Outcomes of VT Ablation in Ischemic Compared to Non‐Ischemic Dilated Cardiomyopathy},
journal = {Annals of Noninvasive Electrocardiology},
year = {2025},
doi = {10.1111/anec.70126}
}
EUVIMED